Clinical Scorecard: Comprehensive Evaluation of Fatigue in Brain Metastasis Patients Pre- and Post-Gamma Knife Radiosurgery
At a Glance
Category
Detail
Condition
Fatigue in patients with brain metastases undergoing Gamma Knife radiosurgery
Key Mechanisms
Fatigue is multifactorial, associated with psychological factors (anxiety, depression), Karnofsky Performance Status, and global health deterioration rather than tumor volume or number
Target Population
Adult patients with 1–10 brain metastases, KPS ≥ 70, scheduled for Gamma Knife radiosurgery
Fatigue is the most frequently reported and distressing symptom in brain tumor patients, negatively impacting quality of life.
Multidimensional fatigue assessment (general, physical, mental, reduced activity, reduced motivation) provides a comprehensive evaluation compared to unidimensional measures.
Fatigue levels in brain metastasis patients increase over 6 months post-Gamma Knife radiosurgery and are influenced by psychological status and functional performance rather than tumor burden.
Guideline-Based Recommendations
Diagnosis
Use multidimensional self-report questionnaires such as the Multidimensional Fatigue Inventory (MFI) to assess different fatigue aspects.
Compare fatigue levels to age- and sex-matched non-cancer controls using normative data and Z scores.
Screen for psychological factors including anxiety and depression as part of fatigue evaluation.
Management
Consider psychological support and interventions targeting anxiety and depression to manage fatigue.
Monitor Karnofsky Performance Status as an indicator of fatigue severity and functional status.
Provide usual care MRI and clinical follow-up at 3 and 6 months post-Gamma Knife radiosurgery.
Monitoring & Follow-up
Perform fatigue assessments at baseline (pre-treatment), and at 3 and 6 months post-treatment.
Evaluate treatment response via MRI to classify disease status (partial response, stable disease, progressive disease).
Track changes in fatigue dimensions longitudinally to identify worsening or improvement.
Risks
Fatigue may worsen post-Gamma Knife radiosurgery in a majority of patients.
Lower Karnofsky Performance Status (<90) is associated with worse fatigue outcomes.
Psychological distress can exacerbate fatigue independent of tumor characteristics.
Patient & Prescribing Data
Adults with 1–10 brain metastases, KPS ≥ 70, no prior brain radiation or surgery, excluding small cell lung cancer and meningeal disease
Gamma Knife radiosurgery doses of 18–25 Gy with strict organ at risk limits are used; fatigue should be monitored as a common post-treatment symptom with multidimensional tools.
Clinical Best Practices
Incorporate multidimensional fatigue assessments into routine clinical evaluations for brain metastasis patients.
Use normative data adjusted for age and sex to interpret fatigue scores accurately.
Address psychological comorbidities proactively to mitigate fatigue impact.
Schedule follow-up assessments aligned with MRI scans at 3 and 6 months post-treatment.
Educate patients about the potential for increased fatigue following Gamma Knife radiosurgery.
